Rein Therapeutics develops inhaled drug candidates for rare lung diseases, led by a treatment for idiopathic pulmonary fibrosis. It last closed at $0.34 on Nov 20, down 8.38% on the day. For the quarter ended Sep 2026, RNTX reported EPS of -$0.06 on revenue of $0. Over its last 5 reports the stock moved an average of 8.3% the session after earnings. Over the last 12 months RNTX insiders bought $75K of stock on the open market and sold $0, according to SEC Form 4 filings.
AI Auto Pilots
Is RNTX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold RNTX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on RNTXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
RNTX · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 68% below its 20 day and 97% below its 50 day average. It is 191% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 25), oversold. The nearest support is the Pivot S1 at $0.32, and the nearest resistance the Pivot at $0.35.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 22.3%/day
Key levels
$2.1052 week high+517.6%
$0.98200 day average+188.2%
$0.75100 day average+120.6%
$0.6650 day average+94.1%
$0.65Swing high (Oct 21)+91.2%
$0.5720 day average+67.6%
$0.37Pivot R1+8.8%
$0.35Pivot+2.9%
$0.34Last close
$0.32Pivot S1−5.9%
$0.2852 week low−17.6%
$0.28Swing low (Nov 16)−17.6%
Indicators
RSI (14)
24.71
Oversold below 30
Oversold
MACD
-0.09
Below its signal line
Bearish
Stochastic
15.5
Near the bottom of its range
Oversold
ADX (14)
31.6
Trending down
Williams %R
-88.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-140.5
Oversold below −100, overbought above 100
Oversold
Rate of change
−45.1%
Change over 10 sessions
Bearish
ATR (14)
$0.08
Typical daily range, 22.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 53.5%/day
Key levels
$2.1052 week high+517.6%
$0.98200 day average+188.2%
$0.75100 day average+120.6%
$0.6650 day average+94.1%
$0.65Swing high (Oct 21)+91.2%
$0.5720 day average+67.6%
$0.37Pivot R1+8.8%
$0.35Pivot+2.9%
$0.34Last close
$0.32Pivot S1−5.9%
$0.2852 week low−17.6%
$0.28Swing low (Nov 16)−17.6%
Indicators
RSI (14)
29.45
Oversold below 30
Oversold
MACD
-0.15
Below its signal line
Bearish
Stochastic
12.2
Near the bottom of its range
Oversold
ADX (14)
11.8
No clear trend
Williams %R
-92.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-244.3
Oversold below −100, overbought above 100
Oversold
Rate of change
−57.1%
Change over 10 sessions
Bearish
ATR (14)
$0.18
Typical daily range, 53.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for RNTX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how RNTX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow RNTX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for RNTXHow many large options trades hit RNTX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in RNTX in the last 90 days.
From SEC Form 4 filings by RNTX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RNTX is in one of them and how their past RNTX trades turned out.
Rein Therapeutics is a biopharmaceutical company based in Austin, Texas, that develops treatments for rare lung diseases with few effective options. Its lead candidate, LTI-03, is an inhaled peptide being studied for idiopathic pulmonary fibrosis, a progressive lung disease. The company has paused work on its other candidates while it focuses on LTI-03. Its target patients are people living with lung fibrosis and related conditions.